Day: January 20, 2021

PARSIPPANY, NJ, Jan. 20, 2021 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that it will hold its third quarter 2020 financial results conference call and webcast after the close of market on Thursday, January 21, 2021 at 4:30 p.m. ET.        Purpose: To update the market on Interpace’s third quarter 2020 financial results        Date and Time: Thursday, January 21, 2021 at 4:30 p.m. ET        Dial-in Number (Domestic): +1 (877) 407 – 9716        Dial-in Number (International): +1 (201) 493 – 6779        Conference ID: 13714992        Webcast Access: http://public.viavid.com/index.php?id=143006All listeners should confirm they are dialing in for the Interpace Biosciences conference call with the operator who will promptly place them into the call. A webcast replay will be available on...

ROSELAND, N.J., Jan. 20, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE American:MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent relating to the disposable component of Milestone’s CompuFlo® Instrument.Dr. Mark Hochman, D.D.S., Inventor and Clinical Director for Milestone Scientific, commented, “Our clinical objectives have always been to focus on creating greater control and safety of our disposables. This aligns with our commercial strategy to ensure our disposables are protected due to the high margin, recurring revenue nature of these sales. This patent will cover the unique interactions of the disposable...

Stockholm, January 20, 2021 – On December 29, 2020, Anoto Group AB (publ) (“Anoto” or the “Company”) published a press release regarding that the Company had agreed with Rothesay Limited, an international investor active in the Swedish market (“Rothesay”), to carry out a directed rights issue of 9,000,000 ordinary shares to Rothesay and that the board of directors of the Company at a later time would call for an extraordinary general meeting to approve an additional directed rights issue of 21,000,000 ordinary shares to Rothesay.Against this background, the board of directors of Anoto has resolved on a directed rights issue of 21,000,000 ordinary shares at a subscription price of SEK 0.90 per share and to call for an extraordinary general meeting on February 15, 2021. The board of directors proposes that the extraordinary general meeting...

Stockholm, 20 januari 2021 – Den 29 december 2020 offentliggjorde Anoto Group AB (”Anoto” eller ”Bolaget”) att Bolaget kommit överens med Rothesay Limited (”Rothesay”), en internationell investerare verksam på den svenska marknaden, om att genomföra en riktad nyemission om 9 000 000 stamaktier till Rothesay samt att styrelsen för Anoto vid senare tillfälle skulle kalla till extra bolagsstämma för godkännande av ytterligare en riktad nyemission till Rothesay om 21 000 000 stamaktier.Mot denna bakgrund har styrelsen i Anoto beslutat om att genomföra en riktad nyemission av21 000 000 stamaktier till en teckningskurs om 0,90 SEK per aktie samt att kalla till extra bolagsstämma den 15 februari 2021. Styrelsen föreslår att extra bolagsstämman godkänner styrelsens beslut om riktad nyemission. Kallelse till bolagsstämman kommer att offentliggöras...

NEW YORK, Jan. 20, 2021 (GLOBE NEWSWIRE) — Hennessy Capital Investment Corp. V (NASDAQ: HCICU) (the “Company”) announced today that it closed its upsized initial public offering of 34,500,000 units, including 4,500,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $345,000,000. The units are listed on The Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “HCICU” on January 15, 2021. Each unit consists of one share of the Company’s Class A common stock and one-fourth of one redeemable warrant, each whole warrant enabling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising...

LAS VEGAS, Jan. 20, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is pleased to provide a text version of its Shareholder Roundtable conference call following technical problems.The following are actual questions asked by current or prospective ISW Holdings investors, with answers provided by the Company’s President and Chairman, Alonzo Pierce.Question: “Can you make a case for your company being an investment vs. a day trade and plans for a run to NASDAQ?”Pierce: Our goal is to become a NASDAQ traded company. Our first stop will be an uplist to the OTCQB. We have made incredible strides over the past 18 months, demonstrating strong commercial growth in our Telehealth and Home Healthcare segment while investing...

MORRISVILLE, Vt., Jan. 20, 2021 (GLOBE NEWSWIRE) — Union Bankshares, Inc. (NASDAQ – UNB) today announced results for the three months and year ended December 31, 2020. Net income was $3.8 million and $12.8 million for the three months and year ended December 31, 2020, resulting in earnings per share of $0.85 and $2.86 for the same periods, respectively.The Board of Directors also declared a cash dividend of $0.33 per share for the quarter, an increase of 3.1% from the cash dividend of $0.32 paid in recent prior quarters, payable February 5, 2021 to shareholders of record as of February 1, 2021.President and CEO David Silverman commented on the year end results, “As we look back at 2020, we thank our employees who have persevered through difficult times, handled unprecedented volumes of work, and adapted to new ways of...

CHICAGO (États-Unis), 20 janv. 2021 (GLOBE NEWSWIRE) — PureCircle et Almendra sont parvenus à un règlement amiable de leur litige sur des brevets américains concernant les produits Steviarome® d’Almendra, ainsi que leur usage.Le 31 décembre 2020, PureCircle et Almendra ont résolu leur différend à l’amiable en rejetant l’ensemble des réclamations et recours ultérieurs.Dans le cadre de ce règlement, Almendra a signé un accord de licence avec PureCircle qui autorise Almendra à continuer de commercialiser ses ingrédients aromatiques Steviarome® dans le monde entier. Toutes les autres modalités de l’accord demeurent confidentielles.Demandes de renseignements :Jackson Pillow, responsables des communications de PureCircleE-mail : Jackson.Pillow@purecircle.com Tél. : +1 (630) 256 8394Kimberly Hunter, Directrice financière...